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ABSTRACT 
Objective: To develop and validate a simple, selective, precise and accurate method for the estimation of rupatadine fumarate in bulk and tablet 
dosage form by using the single point standardization method as per international conference on harmonization (ICH) guidelines. 
Methods: In this proposed method, the absorbance of a standard solution of known concentration and a sample solution was measured. From this, 
the concentration of the unknown can be calculated.  
Results: Rupatadine fumarate showed maximum absorbance at 246 nm with methanol. Linearity was checked in different concentrations. The 
calibration curve was obtained in the range of 2-10 µg/ml. The slope, intercept and correlation coefficient (R2
Conclusion: The developed single point standardization method for the estimation of Rupatadine fumarate was found to be simple, precise, accurate, 
reproducible and cost-effective. Statistical analysis of the developed method confirms that the proposed method is an appropriate and it can be useful 
for the routine analysis. The proposed method gives the basic idea to the researcher who is working in the area like product development.  
) values of Rupatadine fumarate were 
found to be 0.047, 0.0034 and 0.9995 respectively. Intra-day and inter-day precision studies were carried out and there % RSD values were found 
within limits i.e. less than 2%. The recovery studies were carried out by adding a known amount of standard drug to preanalysed formulation and % 
Recovery was found to be within 99.7-101.6%. LOD and LOQ of Rupatadine fumarate were found to be 0.1 µg/ml and 0.3 µg/ml respectively. 
Robustness studies were performed at different wavelengths and the % RSD was found within the limits i.e. less than 2 %. 
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Rupatadine fumarate [(E)-but-2-enedioic acid: 8-chloro-11-[1-[(5-
methylpyridine-3-yl) methyl] piperidin-4-ylidene] 5, 6-dihydrobenzo 
[1, 2] cyclo hepta [2, 4-b] pyridine], with molecular weight of 532.037 
g/mol [1]. It is a second generation antihistamine and a PAF antagonist 
used to treat allergies. It blocks H1
UV spectrophotometric analysis is based on measuring the 
absorption of monochromatic light by colorless compounds in the 
near of the UV path of the spectrum [200-400 nm]. The photometric 
method of analysis is based on beer’s-lamberts law, which states 
that the absorbance of a solution is directly proportional to the 
concentration of the absorbing species in the solution and the path 
length [3]. Thus, for a fixed path length, UV spectroscopy can be used 
to determine the concentration of absorber in a solution [4-5].  
 and PAF (platelet activating factor) 
receptor and prevents their mediators from exerting their effects and 
reduces the severity of allergic symptoms [2]. 
As per the past literature survey, Rupatadine fumarate was 
estimated by different spectroscopic and chromatographic 
techniques such as, UV-Visible spectroscopic method by using 
different reagents [6-7], UV spectroscopic method for the estimation 
of Rupatadine fumarate in tablet dosage form [8], AUC and first-
order derivative methods [9] and RP-HPLC technique [10, 11]. 
Hence the present study aims to develop and validate a simple, 
precise, and accurate UV spectrophotometric method for the 
estimation of Rupatadine fumarate in bulk and tablet dosage form 
by using the single point standardization method. 
MATERIALS AND METHODS 
Chemicals and reagents 
Rupatadine fumarate was obtained as a gift sample from Medrich 
pharma company, Bangalore. Methanol-AR grade and Distilled water. 
Instruments used 
Electronic weighing balance-SHIMADZU-model-ELB300, sonicator-
Ultrasonicator-model-2200MH, agilent UV-Visible spectrophotometer-
model-Cary 60. 
Method used 
The single point standardization procedure involves the 
measurement of the absorbance of a sample solution and of a 
standard solution of a reference substance having the same 
concentration. From this concentration of the sample was calculated 
[12]. 
Experimental work 
Selection of solvent 
The solubility of the drug was performed with different solvents. 
Rupatadine fumarate was freely soluble in methanol. The drug 
showed a good absorbance spectrum and was stable in methanol, 
hence methanol was selected as the solvent. The solubility profile of 
Rupatadine fumarate was given in table 1. 
Preparation of standard stock solution 
Weighed accurately about 50 mg Rupatadine fumarate reference 
standard and transferred into 50 ml volumetric flask. Then dissolved 
and diluted up to the mark with methanol to give a stock solution 
having strength 1 mg/ml or 1000µg/ml. 
Determination of absorption maxima 
The above stock solution was further diluted with distilled water to 
get a concentration of 10 µg/ml and scanned under UV between 
200-400 nm by taking distilled water as blank. The maximum 
absorbance wavelength of Rupatadine fumarate was found at 246 
nm as shown in (fig. 1). 
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Working standard solutions of the drug having concentration 2, 4, 6, 
8 and 10µg/ml were prepared by diluting the standard stock 
solution with distilled water. The absorbance of resulting solutions 
was measured against the solvent blank and a calibration curve was 
plotted to get the linearity and the regression equation [13] which 
was shown in (fig. 2) and the result was shown in table 2.  
Single point standardization 
Measurement of absorbance of the sample solution and a standard 
solution of a reference substance was done. It was observed that 
the concentration of the standard solution was close to that of the 
sample solution. The concentration of a substance in the sample 
was calculated from the proportional relationship that exists 
between absorbance and concentration [14]. The results were 




 X Cstd 
Preparation of sample solution 
Weighed 20 tablets and powered it. The quantity of powder 
equivalent to 10 mg was taken and transferred into a 100 ml 
volumetric flask, dissolved in methanol and volume made with 
distilled water. From the above solution, 10 µg/ml solution was 
prepared by diluting with distilled water and measured under UV-
Visible spectrophotometer at 246 nm. From this concentration was 
found by using an earlier equation. The amount of drug present in 
the formulation can be found by, 
Amount =  
Concentration X Dilution Factor X Average Weight
Weight Taken 
 
The results were shown in table 4.  
Method validation  
Specificity 
By diluting the stock solution, 10µg/ml solution was prepared and 
the absorbance was measured at 246 nm against the blank. The 
result was shown in table 5. 
Precision 
Repeatability (Intraday precision)  
2, 4 and 6 µg/ml solutions of Rupatadine fumarate was prepared, 
whose absorbance was measured six times at 246 nm at different 
time intervals and the relative standard deviation was calculated. 
The results were shown in table 6. 
Reproducibility (Interday precision)  
Six individual preparations of Rupatadine fumarate were prepared 
with different concentrations of 2,4 and 6 µg/ml and the absorbance 
were measured at 246 nm. The relative standard deviation was 
calculated. The results were shown in table 7. 
Accuracy 
A known quantity of the standard drug was added to the 
preanalysed sample formulation at 50%, 100% and 150% levels and 
the contents were reanalyzed by the proposed method. The results 
were shown in table 8. 
%R
=  
Amount of drug found Amount of drug found
after the addition of standard drug −  before the addition of standard drug
Amount of standard drug added 
X100 
Where, %R= % recovery 
Limit of detection 
It was performed by based on the visual evaluation method. It was 
determined by the analysis of the sample with a known 
concentration of analyte and by establishing the minimum level at 
which the analyst is reliably detected. The result was shown in 
table 9. 
Limit of quantitation 
It was performed based on the visual evaluation method. It was 
determined by the analysis of the sample with a known 
concentration of analyte and by establishing the minimum level of 
which the analyst can be quantified with acceptable accuracy and 
precision. The result was shown in table 10. 
Robustness 
10 mg/ml concentration of Rupatadine fumarate was prepared, 
whose absorbance was measured in three different wavelengths like 
243, 246 and 249 nm closer to the λmax
RESULTS AND DISCUSSION 
 of the drug. The results were 
shown in table 11. 
Method development parameters 
Solubility studies 
Rupatadine fumarate was freely soluble in methanol, ethanol and glacial 
acetic acid [GAA] partially soluble in chloroform and insoluble in water. 
Determination of absorption maxima 
The stock solution was further diluted with distilled water to get a 
concentration of 10µg/ml and scanned under UV between 200 nm-
400 nm. The absorption maximum of Rupatadine fumarate was 
found at 246 nm. 
Calibration curve 
Calibration curve was performed in the concentration range of 2-10 
µg/ml. Regression coefficient (R2
10 µg/ml concentration containing standard solution and equivalent 
to 10 µg/ml sample solution was prepared. The absorbance of both 
solutions was measured at 246 nm. From this, the sample 
concentration was found as 10.02 µg/ml. 
) was found to be 0.9995. 
Single point standardization method 
 
Table 1: Solubility profile of Rupatadine fumarate 
S. No. Solvents Solubility 
1 Methanol Freely soluble 
2 Ethanol Freely soluble 
3 Glacial acetic acid Freely soluble 
4 Chloroform Partially soluble 
5 Water Insoluble 
 
Table 2: Calibration curve values of Rupatadine fumarate 
S. No. Concentration (µg/ml) Absorbance 
1 2 0.0866 
2 4 0.1898 
3 6 0.2796 
4 8 0.3707 
5 10 0.4661 
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Fig. 1: UV absorption spectra of Rupatadine fumarate 
 
 
Fig. 2: Calibration curve of rupatadine fumarate 
 
Table 3: Concentration of rupatadine fumarate in sample 
S. No. Concentration of standard (µg/ml) Absorbance of standard Absorbance of sample Concentration of sample(µg/ml) 
1 10 0.4564 0.4575 10.02 
By substituting the concentration of sample solution in the formula which was mentioned in the methodology the amount was found as follows. 
 
Table 4: Amount of rupatadine fumarate in sample 
S. No. Rupatadine fumarate Label claim (mg) Amount found (mg) SD %RSD 
1 Tablet 10 10.2  
0.1000 
 
0.9801 2 Tablet 10 10.3 
3 Tablet 10 10.3 





Table 5: Specificity of rupatadine fumarate 














SD= standard deviation, %RSD= relative standard deviation 
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Intraday precision studies were performed in 2, 4 and 6 µg/ml 
concentrations and the relative standard deviation was found to be 
within limits i.e. less than 2%. Hence the performed parameter was 
validated. 
Inter-day precision 
Inter-day precision studies were performed in 2, 4, and 6 µg/ml 
concentrations and the relative standard deviation was found to be 
within limits i.e. less than 2%. Hence the performed a parameter was 
validated. 
Accuracy 
Accuracy studies were performed at 50%, 100%, and 150% levels 
by spiking 2, 4 and 6 µg/ml standard solutions to pre analysed 
sample solution. The % Recovery was found to be within the limits, 
i.e. in the range of 99.7-101.6. 
Limit of detection 
Limit of detection of Rupatadine fumarate was performed by the 
visual evaluation method and the result was found to be 0.1 µg/ml. 
Limit of quantification 
Limit of quantification of Rupatadine fumarate was performed by 
the visual evaluation method and result was found to be 0.3 µg/ml. 
 
Table 6: Intraday precision of rupatadine fumarate 


















































SD= standard deviation, %RSD= relative standard deviation 
 
Table 7: Inter-day precision of Rupatadine fumarate 

















































SD= standard deviation, %RSD= relative standard deviation 
 
Table 8: % Recovery of rupatadine fumarate 
S. 
No. 
level Amount of drug in the sample 
(µg/ml) 
Amount of standard drug added 
(µg/ml) 
Amount of drug recovered 
(µg/ml) 
%Recovery 
1 50% 10 2 2.032 101.6 
2 100% 10 4 4.012 100.6 
3 150% 10 6 5.983 99.7 
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Table 9: Limit of detection of rupatadine fumarate 
S. No. LOD value Absorbance 
1 0.1 µg/ml 0.0145 
LOQ= Limit of quantification 
 
Table 10: Limit of quantification rupatadine fumarate 
S. No. LOQ Value Absorbance 
1 0.3 µg/ml 0.0423 
LOQ= Limit of quantification 
 
Robustness 
Robustness of the method is its ability to remain unaffected by small 
changes in parameter such as changes in wavelength, changes in 
temperature, etc. robustness examine the effect of operational 
parameter on the analytical method. 10µg/ml concentration of 
Rupatadine fumarate was prepared, whose absorbance was 
measured in three different wavelengths like 243, 246 and 249 nm 
closer to λmax
 
 of the drug. The % relative standard deviation was 
found within the limits i.e. less than 2%. 
Table 11: Robustness of rupatadine fumarate 














































SD= Standard deviation, %RSD= %Relative standard deviation 
 
CONCLUSION 
The developed UV spectrophotometric method for the estimation of 
Rupatadine fumarate in bulk and tablet dosage form by using the 
single point standardization method was found to be simple, precise, 
accurate, reproducible and cost-effective. The statistical analysis of 
the developed method conforms that the proposed method is an 
appropriate and it can be used for routine analysis. 
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